Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues-Reference-Cited by-同舟云学术

Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues

Published:2022-08 Issue: Volume:82 Page:105370
ISSN:0887-2333
Container-title:Toxicology in Vitro
language:en
Short-container-title:Toxicology in Vitro

Author:

Nandikolla Adinarayana,Mahadu Khetmalis Yogesh,Mahalakshmi Naidu Kalaga,Karan Kumar Banoth,Murugesan Sankaranarayanan,Chandra Sekhar Kondapalli Venkata Gowri

Funder

Council of Scientific & Industrial Research

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference45 articles.

1. Evaluation of antimycobacterial activity of a sulphonamide derivative;Agertt;Tuberculosis,2013

2. The totally drug resistant tuberculosis (TDR-TB);Akbar Velayati;Int. J. Clin. Exp. Med.,2013

3. Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 4-{4-[2-(4-(2-substitutedquinoxalin-3-yl)piperazin-1-yl)ethyl] phenyl}thiazoles as atypical antipsychotic agents;Chandra Sekhar;Med. Chem. Res.,2013

4. Microplate Alamar blue assay versus BACTEC 460 system for high- throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium;Collins;Antimicrob. Agents Chemother.,1997

5. E-2-[3-(3,4-Dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1, 4-dioxide: a lead antitubercular agent which alters mitochondrial respiration in rat liver;Das;Eur. J. Med. Chem.,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the Inhibitor Targeting the SLC7A11/xCT Axis through In Silico and In Vitro Experiments;International Journal of Molecular Sciences;2024-07-29

2. Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline‐isoxazole‐piperazine conjugates as EGFR‐targeting agents;Chemical Biology & Drug Design;2024-03

3. Electrochemical Reduction of 2-Substituted Quinoxalines in Aprotic Medium and in Conditions of Protonation;ANAL BIOANAL ELECTRO;2023